Health Literacy Interventions for Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how different messages about smoking's health risks influence smokers' attitudes and intentions to quit. Participants will hear one of four message types that combine facts and emotions, emphasizing either the benefits of quitting or the costs of not quitting, to determine which is most effective. The trial targets smokers who have smoked at least 5 cigarettes a day for the past year and can communicate in English. The goal is to understand how these messages affect smokers' thoughts and feelings about quitting, potentially aiding in the development of more impactful anti-smoking campaigns. As an unphased trial, it offers participants the chance to contribute to research that could shape more effective anti-smoking strategies.
Will I have to stop taking my current medications?
The trial requires that you are not currently using nicotine replacement therapy or bupropion. If you are using these, you would need to stop before participating.
What prior data suggests that these health literacy interventions are safe for participants?
Research shows that the treatments in this trial—different types of messages about smoking—are very safe. Previous studies have found that using factual and emotional messages about the risks of smoking does not cause any health problems. These messages are audio recordings and written text designed to influence thoughts and attitudes about quitting smoking.
The trial examines four types of messages: factual positive, factual negative, emotional positive, and emotional negative. These are not medications or physical treatments, so there are no side effects to worry about. The goal is to understand how different message styles affect smokers' intentions to quit and their views on smoking.
Participating in this kind of messaging study is generally very safe. Participants simply listen to or read messages, with no risk of physical harm from these communications. Therefore, safety should not be a concern for those considering joining this study.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different ways of framing health messages can impact smoking behavior. Unlike traditional smoking cessation programs that often focus on behavioral therapy or pharmacological aids, this trial examines four unique messaging strategies: factual loss-framed, emotional loss-framed, factual gain-framed, and emotional gain-framed. These strategies aim to tap into the psychological aspects of decision-making by presenting information about smoking risks in varied emotional and factual contexts. The hope is to uncover which type of message is most effective at encouraging smokers to quit, potentially leading to more personalized and effective public health campaigns.
What evidence suggests that this trial's interventions could be effective for smoking cessation?
This trial will compare different types of smoking risk messages. Research has shown that the method used to encourage smokers to quit can make a difference. Participants in this trial will receive either factual or emotional messages. Factual messages, particularly for those who understand health information well, can increase awareness of risks and boost confidence in quitting. Emotional messages, however, can be more effective overall, especially when focusing on the negative effects of smoking. This trial will test both loss-framed messages, which highlight potential losses from continuing to smoke, and gain-framed messages, which emphasize the benefits of quitting. Studies suggest that loss-framed messages can be more convincing, but gain-framed messages can also be effective, particularly in helping individuals achieve early success in quitting. Overall, the impact of these messages can vary based on an individual's understanding of health information and their perception of risk.35678
Who Is on the Research Team?
Lorna McNeill
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for English-speaking smokers aged 18 to 70 who have smoked at least 5 cigarettes daily over the past year. They must have a home address, phone number, and not be using nicotine replacements or enrolled in cessation programs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Focus Group
Participants complete questionnaires and participate in a focus group to discuss and evaluate smoking risk informational messages
Pilot Testing and Main Study
Participants complete questionnaires, a breath test, and computer-aided tasks to evaluate smoking risk messages
Follow-up
Participants are monitored for understanding and response to smoking health risk informational messages
What Are the Treatments Tested in This Trial?
Interventions
- Focus Group
- Questionnaire
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator